Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …

Metformin, one of the first-line of hypoglycemic drugs, has cardioprotective, anti-
inflammatory and anticancer activities, in addition to its proven hypoglycemic effects …

Background: Lifestyle intervention and metformin have been shown to prevent diabetes;
however, their efficacy in preventing cardiovascular disease associated with the …

Metformin, a biguanide drug, is the most commonly used first-line medication for type 2
diabetes mellites due to its outstanding glucose-lowering ability. After oral administration of …

Introduction Several studies have explored the effect of anthropometric risk factors on
metabolic syndrome. However, no systematic effort has explored the effect of overweight …

With the recent rapid increase in obesity worldwide, metabolic syndrome (MetS) has gained
significant importance. MetS is a cluster of obesity-related cardiovascular risk factors …

Abstract Purpose Metabolic syndrome (MetS) is a major risk factor for cardiovascular
diseases and type-2 diabetes. The study aimed to establish the efficacy of a community …

Aims The impact of behavioural risk factors on the metabolic syndrome has not been well
understood by the researchers. This information is important to the policymakers for …

This study aimed to examine changes in physical activity (PA) during a behavioral weight
loss intervention and to determine baseline factors associated with PA goal achievement …

Introduction COVID-19 is currently a global pandemic, and initial reports of identified COVID-
19 lockdown and limitations can adversely affect childhood obesity and metabolic health …